Interestingly, studies show that approximately two thirds of children given a diagnosis of classical atopic dermatitis are, in fact, not sensitized to allergens. 4 As a result, atopic dermatitis is a commonly used misnomer, prompting the World Allergy Organization to recommend in 2003 that the terms atopic dermatitis and atopic eczema be applied exclusively to atopic patients. 5 The atopic march refers to the natural history of atopic manifestations, with a typical progression from atopic dermatitis to asthma and allergic rhinitis. 6 Several studies hypothesize a causal pathway, [6] [7] [8] [9] [10] [11] including documentation of atopic comorbidities during a clinical trial of atopic dermatitis treatment 10 and a large retrospective study of atopic comorbidities based on health care provider diagnostic data. Other studies suggest that the atopic march might oversimplify the natural history of childhood atopy. 12, 13 The connection between atopic dermatitis and asthma might be skin barrier dysfunction, specifically loss-of-function variants of the gene encoding filaggrin (FLG), a skin matrix protein that promotes aggregation of keratin filaments. 14 In the German Multicenter Allergy Study birth cohort FLG variants were highly predictive of asthma in children with eczema and sensitization to food allergens. 15 In the Isle of Wight birth cohort, allergic sensitization and eczema status were found to be independent effect modifiers of the relationship between FLG variants and asthma but not rhinitis. 16 Because FLG genotyping is not typically available in clinical management, 9 alternative prognostic approaches for children with atopic dermatitis are needed. In particular, there has been a call for well-conducted longitudinal studies that compare differences in prognosis between sensitized and nonsensitized children. 4 This is especially important considering the global epidemic of asthma, allergy, and allergic rhinitis. 17 The Canadian Healthy Infant Longitudinal Development (CHILD) study 18 is a multicenter prospective birth cohort established to determine the root causes of allergic diseases in children. Here we investigated whether allergic sensitization enhances associations between atopic dermatitis in infancy with subsequent allergic diseases, including asthma, allergic rhinitis, food allergy, and persistent atopic dermatitis.
METHODS

Study design and cohort
The CHILD study is a multicenter longitudinal cohort of 3495 Canadian infants recruited during pregnancy and followed from birth to age 5 years. Child health questionnaires and clinical assessments of allergic diseases were conducted at regular intervals, including 1 and 3 years of age. The current analysis involves 2311 children who had complete data for clinical assessment at age 1 and 3 years, and all required adjustment variables.
Assessment of allergic sensitization
At age 1 year, children were administered epicutaneous skin tests to a battery of 6 inhalant (Alternaria alternata, cat hair, dog epithelium, house dust mites [Dermatophagoides pteronyssinus and Dermatophagoides farinae], and German cockroach) and 4 food (cow's milk, egg white, peanut, and soybean) allergens. As in our previous epidemiologic studies, [19] [20] [21] [22] [23] [24] children were considered sensitized if they produced a wheal 2 mm or larger than that elicited by the negative control (glycerin) to at least 1 of the allergens. In cases in which skin tests were refused, some parents provided the results of external tests performed by other physicians, which were used to determine atopic status.
Assessment of allergic diseases
At the clinical assessment at age 1 year, the CHILD study physicians (A.B.B., P.J.M., P.S., and S.E.T.; all experienced pediatricians specializing in allergy and asthma) or other highly trained health care professional under their direction answered the question ''Does this child meet the criteria for diagnosis of atopic dermatitis?'' with the options ''yes'' or ''no.'' These criteria were derived from the UK Working Party document, 25 namely an itchy skin condition with 1 or more of the following: a history of involvement of the skin creases of elbows, behind the knees, in front of the ankles, or around the neck; a history of general dry skin in the last year; or visible flexural eczema or eczema involving the cheeks/foreheads and outer limbs. At the clinical assessment at age 3 years, the CHILD study physician or health care professional undertook a careful assessment of the clinical history during the past year and then responded to the following question: ''In your opinion, does the child have any of the following: asthma, allergic rhinitis, food allergy, atopic dermatitis (Yes/Possible/No)?'' Children were considered to have the outcome only if the response was definitively ''yes.'' All diagnoses were reviewed by the study physician.
Covariate measures
Covariates considered in the study were child sex, study center, first-born status, ethnicity, household income, parental atopy based on skin prick testing, and parental self-reported history of allergic diseases (asthma, allergic rhinitis, food allergy, or atopic dermatitis). Parental atopy and disease history were considered positive if at least 1 of the parents had a positive test response (> _2-mm wheal to any allergen) or reported an allergic history. When data were missing for 1 parent and the other parent had a negative result, the child was considered not to have a parental history for atopy or allergic disease. Parental ethnicity was used to define child ethnicity, with a child considered white if at least 1 parent was white.
Statistical analysis
The relationship between atopic dermatitis and allergic sensitization at age 1 year with the outcomes of allergic disease at age 3 years was assessed by using multivariable modified Poisson regression. 26 Relative risks (RRs) and adjusted relative risks (aRRs) were calculated for both unadjusted and adjusted (for child's sex, study center, ethnicity, parental history of allergic diseases, and pet ownership) effects of atopic dermatitis and allergic sensitization at age 1 year. Interaction between atopic dermatitis and allergic sensitization was assessed in both the multiplicative and additive scales. 27, 28 Multiplicative interaction was assessed by adding an interaction term to the adjusted and unadjusted model.
Relative excess risk due to interaction (RERI) was used to assess for additive interaction, in which an RERI RR value of greater than 0 indicates a positive additive interaction and an RERI RR value of less than 0 indicates a negative additive interaction. Calculation of 95% CIs was done by using the methods of variance estimates recovery. 29 The comparison group consisted of nonsensitized children without atopic dermatitis at age 1 year.
Two sensitivity analyses were undertaken. In the first analysis the definition of sensitization was changed from a wheal size of 2 mm or greater to a wheal size of 3 mm or greater, which is traditionally regarded as indicating clinically relevant sensitization. In the second analysis we excluded children with reported food allergy at age 3 months, 6 months, and/or 1 year to determine whether food allergy at age 3 years was simply a continuation of food allergy from early childhood.
All analyses were conducted with SAS 9.4 software (SAS Institute, Cary, NC).
RESULTS
Study population
At 1 year, among 2311 children eligible for this analysis, 317 (13.7%) were sensitized, with 252 (10.9%) sensitized to 1 or more food allergens and 95 (4.1%) sensitized to 1 or more inhalant allergens (Table I; for data on full cohort, see Table E1 in this article's Online Repository at www.jacionline.org). The most frequent food sensitization was to egg white (7.4%), followed by peanut (5.1%) and cow's milk (1.9%). At the 1-year clinic visit, 265 children were determined to have atopic dermatitis (11.5%). Considering allergic sensitization and atopic dermatitis, 221 (9.6%) children were sensitized but did not have atopic dermatitis, 169 (7.4%) had atopic dermatitis but were not sensitized, 96 (4.2%) had both, and 1825 (78.9%) had neither.
At the 3-year clinic visit, 81 (3.5%) of these 2311 children were considered to have definite asthma (53 received oral or inhaled corticosteroids in the last year), 54 (2.3%) were considered to have allergic rhinitis, 103 (4.5%) were considered to have food allergy, and 250 (10.8%) were considered to have atopic dermatitis.
Associations with asthma at age 3 years
The strongest interaction between atopic dermatitis and sensitization was observed for diagnosed asthma. Assessed independently, both atopic dermatitis (ignoring sensitization) and sensitization (ignoring atopic dermatitis) at age 1 year independently increased the risk of asthma at age 3 years (aRR, 2.23 [95% CI, 1.36-3.67] and 4.37 [95% CI 2.85-6.69], respectively) after adjustment for child's sex, ethnicity, study center, pet ownership, parental atopy, and parental history of any allergic diseases (Table  II) . However, children with atopic dermatitis without allergic sensitization were not at an increased risk (aRR, 0.46; 95% CI, 0.11-1.93) compared with the reference group of nonsensitized children without atopic dermatitis, whereas children with both atopic dermatitis and allergic sensitization had a 7-fold increased risk of asthma (aRR, 7.04; 95% CI, 4.13-11.99) after adjustment as above (Table III) . Atopic dermatitis and sensitization had a significant positive interaction on both the multiplicative (RR ratio, 5.80; 95% CI, 1.20-27.83) and additive (RERI, 5.06; 95% CI, 1.33-11.04) scales (Table III) after adjustment for covariates. When sensitization was further categorized as food or inhalant sensitization, food sensitization and atopic dermatitis had a significant positive interaction on the risk of asthma at age 3 years but only on the additive scale, whereas inhalant sensitization did not (see Tables E2 and E3 in this article's Online Repository at www.jacionline.org).
Associations with allergic rhinitis at age 3 years
Among all children, atopic dermatitis (ignoring sensitization) at age 1 year significantly increased the risk of allergic rhinitis at Table III) .
Associations with food allergy at age 3 years
Atopic dermatitis at age 1 year was associated with an increased risk of food allergy at age 3 years (aRR, 4.61; 95% CI, 3.02-7.05), whereas sensitization at age 1 year was an even stronger risk factor (aRR, 16.47; 95% CI, 10.64-25.49) after adjustment for covariates (Table II) . The presence of both atopic dermatitis and sensitization at age 1 year was associated with a greatly increased risk of food allergy at age 3 years (aRR, 33.79; 95% CI, 18.89-60.47) relative to the reference group of nonsensitized children without atopic dermatitis (Table III) . The presence of sensitization and atopic dermatitis had a highly significant positive interaction on the additive scale (RERI, 15.11; 95% CI, 4.19-35.36) but not on the multiplicative scale (RR ratio, 0.77; 95% CI, 0.29-2.03) after adjustment for covariates (Table III) . Specifically, sensitization to food allergens and atopic dermatitis had significant additive interactive effects on the risk of food allergy at age 3 years; sensitization to inhalant allergens and atopic dermatitis did not interact significantly (see Table E3 ). A sensitivity analysis revealed that excluding children with reported food allergy at age 3 months, 6 months, and/or 1 year did not change the effect of atopic dermatitis and sensitization at age 1 year on food allergy at age 3 years (data not shown but available on request).
Associations with atopic dermatitis at age 3 years
Within the study sample, atopic dermatitis at age 1 year greatly increased the risk of atopic dermatitis at age 3 years (aRR, 3.79; 95% CI, 2.98-4.83; Table II) . Any sensitization at age 1 year also increased the risk of atopic dermatitis at age 3 years, although to a somewhat lesser extent (aRR, 2.43; 95% CI, 1.89-3.12), after adjustment for covariates. Compared with the reference group of nonsensitized children without atopic dermatitis, sensitized children with atopic dermatitis at age 1 year exhibited a 6-fold increased risk of atopic dermatitis at age 3 years (aRR, 6.00; 95% CI, 4.36-8.23; Table III ). However, there was no evidence of an interactive effect between sensitization and atopic dermatitis on the risk of atopic dermatitis either on the multiplicative (RR ratio, 0.89; 95% CI, 0.54-1.45) or additive (RERI, 1.44; 95% CI, 20.61 to 3.81) scale (Table III) .
Unadjusted values can be found in Table E4 in this article's Online Repository at www.jacionline.org. The sensitivity analysis performed with a 3-mm or greater wheal cutoff instead of a 2-mm or greater cutoff to define sensitization yielded similar results that remained consistent across all outcomes (see Table E5 in this article's Online Repository at www.jacionline.org). Fig 1 shows the additive interactions for all allergic outcomes at age 3 years.
DISCUSSION
Atopic dermatitis without concomitant allergic sensitization was not associated with an increased risk of asthma at age 3 years, whereas atopic dermatitis with allergic sensitization increased the risk of asthma more than 7-fold. The presence of both atopic dermatitis and sensitization had positive additive and multiplicative interactions in their effects on asthma. There was a strong positive additive interaction between atopic dermatitis and sensitization in the risk for food allergy, although interaction in the multiplicative scale was not significant. In other words, for asthma, the combined effect of atopic dermatitis and sensitization was greater than the sum of or the product of their individual effects. For food allergy, the combined effect of atopic dermatitis and sensitization at age 1 year was greater than the sum of their individual effects.
Based on the Isle of Wight birth cohort, Ziyab et al 16 reported previously that the effects of eczema and allergic sensitization interacted with the effect of FLG loss-of-function mutations on asthma but not rhinitis. ''Preceding allergic sensitization and filaggrin variants'' and ''preceding eczema and filaggrin variants'' increased the risk of subsequent asthma by 4.93-and 3.33-fold, respectively, in the first 18 years of life. Interaction was assessed on the multiplicative but not the additive scale. In our study we found that the presence of atopic dermatitis with allergic sensitization at age 1 year increased the risk of asthma more than 7-fold at age 3 years, with interacting effects on both the additive and multiplicative scales. Similar to the findings of Ziyab et al, we found no evidence to suggest an interactive effect on the risk of rhinitis. We were able to assess additional allergic outcomes, including atopic dermatitis and food allergy. Notably, atopic dermatitis and allergic sensitization at age 1 year had a Adjusted for ethnicity, study center, child's sex, pet ownership, parental atopy, and parental history of any allergic diseases. Numbers for adjusted models are lower because of missing data required for adjustment. For unadjusted data see Table E4 in this article's Online Repository at www.jacionline.org. àStatistically significant at the .05 level.
highly significant positive interaction in the additive scale on the risk of food allergy.
The finding that sensitized children with atopic dermatitis at age 1 year had a significantly higher risk of food allergy at age 3 years is consistent with previous findings. 8, 9 A potential explanation is that children shown to be sensitized to food allergens at age 1 year who also had atopic dermatitis might have consequently avoided the foods to which they were sensitized. We have previously shown in the CHILD study that children who avoided cow's milk products, egg, and peanut during the first year of life were at increased risk of allergic sensitization to the same foods. 30 A general pattern of delayed feeding was also associated with an increased risk of food sensitization. Because food sensitization is known to be on the pathway to food allergy, food avoidance might explain the substantial proportion of sensitized children with atopic dermatitis who have subsequent food allergy.
The potentially interactive effects of atopic dermatitis and allergic sensitization at age 1 year on allergic outcomes at age 3 years have not been well characterized. Previous studies have typically assessed atopic dermatitis and allergic sensitization as effect modifiers of the relationship between FLG variants and asthma or rhinitis 16 or assessed children with atopic dermatitis and allergic sensitization as a subgroup. 15 A primary strength of our study was the longitudinal, population-based design. This allowed us to determine whether the finding of allergic sensitization in a 1-year-old child provides prognostic value alongside the presence of atopic dermatitis. We addressed this important research question by using objective skin prick test data at age 1 year and longitudinal clinic visit data up to age 3 years, with clear definitions of sensitization and atopic dermatitis. We found that atopic dermatitis and allergic sensitization could be combined to improve the prediction of all 4 of the allergic outcomes in our study. Moreover, we were able to report interaction on both the additive and multiplicative scales, which is a recommended practice in assessing the biological mechanism and public health effect of a disease. 27, 28 Care must be taken in interpreting these results because of the wide CIs for some outcomes resulting from a low number of events at age 3 years.
We have not conducted genotyping for FLG, an epidermal protein that plays an important role in skin barrier function; subjects with FLG-deficient skin are predisposed to atopic dermatitis and have an increased risk of allergic rhinitis, food allergy, and asthma. [31] [32] [33] Although the majority of children with atopic dermatitis do not have an FLG loss-of-function mutation, 34 metaanalysis shows that FLG's effect on atopic dermatitis risk is higher than that of any other confirmed candidate gene for atopic diseases. 35 Incorporating FLG mutations into our analyses alongside atopic dermatitis and allergic sensitization might have further strengthened the prediction of allergic outcomes in our study. However, FLG genotyping is a costly and invasive process that is not usually feasible in the clinical setting.
A potential limitation of our study was that cases of atopic dermatitis classified as definite by physicians or health care professionals during clinical assessments were likely more severe. Infants with milder atopic dermatitis might have been misclassified. 36 Future studies should investigate the relationship between low-to-moderate severity atopic dermatitis and allergic sensitization on the risk for allergic diseases. Additionally, food allergy was not confirmed by using oral challenges in our study, and we do not have a gold standard for the diagnosis of asthma at age 3 years. By using only definitive ''yes'' reports by experienced pediatric allergists and asthma specialists at the clinical visit at age 3 years rather than including reports of ''possible,'' we have a conservative estimate of the prevalence of these diseases; the mix of steroid-treated (65%) and steroid-naive (35%) children given a diagnosis of definite asthma reflects the range of severity of illness in this group.
In conclusion, the atopic march refers to the natural progression of atopic dermatitis to asthma and allergic rhinitis. In a population-based, longitudinal birth cohort we compared allergic disease prognoses between sensitized and nonsensitized children with atopic dermatitis. We found that atopic dermatitis without allergic sensitization was not associated with increased asthma risk. Conversely, the combination of atopic dermatitis and allergic sensitization at age 1 year was associated with an increased risk of asthma and food allergy at age 3 years. The combined effect of atopic dermatitis and allergic sensitization was greater than the sum of their individual effects on the risk of food allergy and greater than the sum or the product of their individual effects on the risk of asthma. Children with atopic dermatitis and evidence of sensitization to common food or inhalant allergens as early as age 1 year represent a high-risk subgroup that warrants further examination in primary intervention studies. 
